title: The Ch1VPP regimen, a risk factor for herpes zoster virus infection in patients treated for Hodgkin's disease.
authors.forename: J
authors.initials: J
authors.lastname: Norum
authors.forename: R M
authors.initials: RM
authors.lastname: Bremnes
authors.forename: E
authors.initials: E
authors.lastname: Wist
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002699:Chlorambucil / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006562:Herpes Zoster / Q000139:chemically induced* / Q000453:epidemiology; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D011344:Procarbazine / Q000008:administration & dosage / Q000009:adverse effects; D012307:Risk Factors; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D002699:Chlorambucil; D011344:Procarbazine; D014747:Vinblastine; D011239:Prednisolone